Combined Effects of Statins and Exercise on Training Sensitive Health Markers

NAActive, not recruitingINTERVENTIONAL
Enrollment

120

Participants

Timeline

Start Date

May 1, 2025

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2026

Conditions
Dyslipidemias
Interventions
DRUG

Atorvastatin 80mg

"Daily intake of 80 mg of the approved drug Atorvastatin. Starting at dose 40 mg with 40 mg weekly increment reaching the maintenance dosage of 80 mg on week two, which is the approved maximum dosage of Atorvastatin. Participants who don't tolerate this fast up-titration may have prolonged tritation protocol (up to four weeks).~Under special circumstances, participants with intolerable side-effects may stay at a lower dose (40 mg/day).~The dosage and applied up-tritation is based on recommendations from trained cardiologists at the National Hospital of the Faroe Islands."

BEHAVIORAL

Exercise

Exercise will be performed as aerobic interval training sessions on cycling ergometers lasting \~45 min, four times weekly for 12 weeks. All exercise sessions will be supervised. Participants will wear HR monitor system during all sessions (Polar Electro Oy, Kempele, Finland) and the Borg 6-to-20 scale will also be used to assess the rate of perceived exertion during exercise sessions. A 4-week ramp-up phase will be applied, consisting of two sessions in weeks 1 and 2, three sessions in weeks 3 and 4 after which participants will complete 4 sessions a week from weeks 5 to 12.

Trial Locations (1)

100

University of the Faroe Islands, Tórshavn

All Listed Sponsors
collaborator

University of Copenhagen

OTHER

collaborator

Research council Faroe Islands

UNKNOWN

collaborator

National Hospital of the Faroe Islands

OTHER_GOV

collaborator

Betri Stuðul

UNKNOWN

lead

University of the Faroe Islands

OTHER